Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Feifel

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Psychiatry (Edgmont (Pa. : Township))|September 30, 2010
When common clinical practice meets evidence-based medicineDavid Feifel
Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
Time to feel good: the therapeutic time course of antidepressantsDavid Feifel
Drug Development Research|November 27, 2016
Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant EffectsDavid Feifel
Psychiatry (Edgmont (Pa. : Township))|September 3, 2009
The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part I-statistics and the case for the "greater good"David Feifel
Evidence-Based Mental Health|August 20, 2013
Limited evidence that benzodiazepines are beneficial in the treatment of disturbed behaviourDavid Feifel
The Journal of General Psychology|May 17, 2007
The effects of cross-fostering on inherent sensorimotor gating deficits exhibited by Brattleboro ratsDavid Feifel, Kristianne Priebe
Brain Research|January 29, 2014
Oxytocin's role in anxiety: a critical appraisalKai MacDonald, David Feifel
The Journal of Sexual Medicine|March 31, 2012
Dramatic improvement in sexual function induced by intranasal oxytocinKai MacDonald, David Feifel
Schizophrenia Research|October 8, 2013
Developing Research Domain Criteria (RDoC) to improve diagnosis and treatment of social deficits in psychiatric disorders: the Mirror Neuron System as a modelFiza Singh, David Feifel
Acta Neuropsychiatrica|June 28, 2012
Oxytocin in schizophrenia: a review of evidence for its therapeutic effectsKai Macdonald, David Feifel
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Psychiatry (Edgmont (Pa. : Township))|September 30, 2010
When common clinical practice meets evidence-based medicineDavid Feifel
Psychiatry (Edgmont (Pa. : Township))|September 1, 2010
Time to feel good: the therapeutic time course of antidepressantsDavid Feifel
Drug Development Research|November 27, 2016
Breaking Sad: Unleashing the Breakthrough Potential of Ketamine's Rapid Antidepressant EffectsDavid Feifel
Psychiatry (Edgmont (Pa. : Township))|September 3, 2009
The use of placebo-controlled clinical trials for the approval of psychiatric drugs: part I-statistics and the case for the "greater good"David Feifel
Evidence-Based Mental Health|August 20, 2013
Limited evidence that benzodiazepines are beneficial in the treatment of disturbed behaviourDavid Feifel
The Journal of General Psychology|May 17, 2007
The effects of cross-fostering on inherent sensorimotor gating deficits exhibited by Brattleboro ratsDavid Feifel, Kristianne Priebe
Brain Research|January 29, 2014
Oxytocin's role in anxiety: a critical appraisalKai MacDonald, David Feifel
The Journal of Sexual Medicine|March 31, 2012
Dramatic improvement in sexual function induced by intranasal oxytocinKai MacDonald, David Feifel
Schizophrenia Research|October 8, 2013
Developing Research Domain Criteria (RDoC) to improve diagnosis and treatment of social deficits in psychiatric disorders: the Mirror Neuron System as a modelFiza Singh, David Feifel
Acta Neuropsychiatrica|June 28, 2012
Oxytocin in schizophrenia: a review of evidence for its therapeutic effectsKai Macdonald, David Feifel
Pageof 12